Treasurer Of The State Of North Carolina Cure Vac N.V. Transaction History

Treasurer Of The State Of North Carolina

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$13.18 - $19.41 $257,919 - $379,834	-19,569 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$14.73 - $35.25 $4,566 - $10,927	310 Added 1.61%	19,569 $384,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $4,383 - $6,268	130 Added 0.68%	19,259 $661,000
Q3 2021 Nov 03, 2021	BUY	$49.26 - $74.5 $31,477 - $47,605	639 Added 3.46%	19,129 $1.05 Million
Q2 2021 Aug 13, 2021	BUY	$56.91 - $127.53 $1.05 Million - $2.36 Million	18,490 New	18,490 $1.36 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.